A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This methodology trial will be conducted in patients with osteoporosis and will measure the
changes in bone quality parameters, micro- and macroarchitecture, bone biomarkers and bone
density following therapy with the approved drug, Forteo.